Streetbeat News

Stock Prices

CFLT

B of A Securities analyst Brad Sills has downgraded Confluent (NASDAQ:CFLT) from Neutral to Underperform and set a price target of $24.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:34 pm

OKE

Truist Securities analyst Neal Dingmann has downgraded ONEOK (NYSE:OKE) from Buy to Hold and set a price target of $68.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:24 pm

DIA

QQQ

SPY

UUP

US stock markets closed higher on November 1st after the Federal Reserve left interest rates unchanged, suggesting that rate hikes might be over. The Dow Jones, S&P 500, and Nasdaq Composite all saw gains. Asian markets were mixed, with Japan's Nikkei 225 and Australia's S&P/ASX 200 closing higher, while China's Shanghai Composite and Shenzhen CSI 300 declined. European stocks rose, with the STOXX 600, DAX, CAC, and FTSE 100 all trading higher. Commodities saw gains in crude oil, gold, silver, and copper, while natural gas declined. US futures were up, while the US Dollar Index declined.

Portfolio Pulse from Akanksha Bakshi

November 02, 2023 | 12:23 pm

CLSD

CYH

MODD

Insiders at Clearside Biomedical, Inc. (CLSD), Community Health Systems, Inc. (CYH), and Modular Medical, Inc. (MODD) have recently made significant purchases of their companies' stocks. CLSD's 10% owner bought 135,778 shares, CYH's Director acquired 1,000,000 shares, and MODD's Director purchased 10,000 shares. This could indicate their confidence in the companies' prospects.

Portfolio Pulse from Lisa Levin

November 02, 2023 | 12:13 pm

CLRB

Cellectar Biosciences is set to release top-line data from its Waldenstrom's Macroglobulinemia (WM) pivotal trial during the JP Morgan Healthcare Conference.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:11 pm

BDC

Belden Inc. has provided its Q4 2023 guidance, expecting EPS of $1.05-$1.20, lower than the estimated $1.62, and revenue of $510M-$530M, lower than the estimated $617.11M. The company attributes this to ongoing demand headwinds, pauses in capital spending by customers, and channel destocking pressures. However, Belden remains optimistic about its long-term prospects due to automation, smart infrastructure, and data integration trends.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:11 pm

NSIT

Insight Enterprises has reiterated its FY23 adjusted EPS forecast to be between $9.40 and $9.60, compared to the estimated $9.47. The company also expects to deliver gross profit growth in the low single digit range.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:10 pm

PCRX

Pacira BioSciences has revised its FY23 net product sales forecast downwards from $550M-$560M to $530M-$540M.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:09 pm

NMM

Navios Maritime Partners (NYSE:NMM) reported Q3 adjusted earnings of $2.68 per share, missing the analyst consensus estimate of $2.80 by 4.29%. This is a 27.17% decrease from the same period last year. However, the company reported quarterly sales of $323.18 million, beating the analyst consensus estimate of $313.03 million by 3.24%, a 0.24% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:08 pm

CRAI

CRA Intl (NASDAQ:CRAI) reported Q3 earnings of $1.13 per share, missing the analyst consensus estimate of $1.39 by 18.71%. This is a 31.1% decrease from the same period last year. The company also reported quarterly sales of $147.55 million, missing the analyst consensus estimate of $158.28 million by 6.78%. This is a 0.60% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 02, 2023 | 12:08 pm